Due to the rapid advancement of immune checkpoint treatment in recent years such as CTLA-4 and PD-1 in AML, scientists have paid more and more attention to the research of immune genes and immune cells [36–40]. The gene discussed is CTLA4; the disease is acute myeloid leukemia.